National Nanotechnology Initiative

In 2000 the Clinton Administration introduced the National Nanotechnology Initiative in the efforts to promote research and development involving nanotechnology ( In 2003 congress enacted 21st Century Nanotechnology Research and Development Act. This act provided a legal base for the National Nanotechnology Initiative to stablish programs, assigned agency responsibilities, funding, and promote research. Currently the National Nanotechnology Initiative consists of individual and collaborative nanotechnology activities of various Federal agencies (National Science and Technology Council, 2014). The National Nanotechnology Initiative creates a framework for shared goals, priorities, and strategies that assist every federal agency participating

1. Advance a world class nanotechnology research and development program. 2. Foster the transfer of new technologies into products for commercial and public benefit. 3. Develop and sustain education resource, a skilled workforce, and a dynamic infrastructure and toolset to advance nanotechnology. 4. Support responsible development of nanotechnology.

The National Nanotechnology Initiative and Office of Science and Technology policy has identified areas in nanotechnology development that requires national support and priority. The Nanotechnology Signature initiatives are a collaboration of multiagency initiatives designed to focus on these emerging technologies. Government funding for nanotechnology has created state-of-the-art centers and research laboratories whose focus is to provide a forum for the development of various nanotechnology related

The priorities of this platform are to focus on nanotechnology based diagnostics, drug delivery and release and regenerative medicine. Their focus is also for the regulations and standardization of products. Address the ethical, safety, environmental and toxicity implications and concerns. Educate the public about nanomedicine and address their perceptions as well as considering the role health care insurance companies and patient organizations play. Funding and grants for programs undertaking by the European Technology Platform is by the European public authorities and European Commission. The Enabling Nanomedicine translation Project (ENATRAS) is a support network whose purpose is to provide and assist with the distribution of nanomedicine programs, research and products throughout